Research Topics
| J H LoflandSummaryAffiliation: Thomas Jefferson University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Pharmacoeconomic fellowships: the need for outcome measuresV Maio
Office of Health Policy and Clinical Outcomes, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
Pharmacoeconomics 19:795-802. 2001..Further research is required to develop these outcome measures, so the effectiveness of pharmacoeconomic fellowship programmes may be assessed...- Palivizumab for respiratory syncytial virus prophylaxis in high-risk infants: a cost-effectiveness analysisJ H Lofland
Office of Health Policy and Clinical Outcomes, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
Clin Ther 22:1357-69. 2000..The cost-effectiveness of this therapy has not been evaluated from the provider's perspective using cost data... - Different approaches to valuing the lost productivity of patients with migraineJ H Lofland
Office of Health Policy and Clinical Outcomes, Thomas Jefferson University, Philadelphia, Pennsylvania 19107 5099, USA
Pharmacoeconomics 19:917-25. 2001..To calculate and compare the human capital approach (HCA) and friction cost approach (FCA) methods for estimating the cost of lost productivity of migraineurs after the initiation of sumatriptan from a US societal perspective... - Cost-effectiveness and cost-benefit of sumatriptan in patients with migraineJ H Lofland
Office of Health Policy and Clinical Outcomes, Thomas Jefferson University, Philadelphia, PA 19107, USA
Mayo Clin Proc 76:1093-101. 2001..To investigate the cost-effectiveness and cost-benefit of initiating sumatriptan therapy in patients with acute migraine who were previously taking nontriptan drugs... - A review of health-related workplace productivity loss instrumentsJennifer H Lofland
Office of Health Policy and Clinical Outcomes, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
Pharmacoeconomics 22:165-84. 2004.... - Health-related workplace productivity measurement: general and migraine-specific recommendations from the ACOEM Expert PanelRonald Loeppke
Health and Productivity Corporation of America, P O Box 1503, Franklin, TN 37065, USA
J Occup Environ Med 45:349-59. 2003..Continued research, validation, and on-going evaluation of health-related productivity instruments are needed... - Effect of health insurance on workplace absenteeism in the U.S. workforceJennifer H Lofland
Department of Health Policy, Thomas Jefferson University, Philadelphia, PA 19107, USA
J Occup Environ Med 48:13-21. 2006..The objectives of this study were to examine the relationship between health insurance (HI) and number of missed workdays (MW), and how it is modified by level of access to care (AC) and healthcare use (HC)... - Workplace absenteeism and aspects of access to health care for individuals with migraine headacheJennifer H Lofland
Health Policy, Thomas Jefferson University, Philadelphia, PA, USA
Headache 46:563-76. 2006..Depression, migraine severity, and health care use are important explanatory variables. Having health insurance may be a confounder between access to care and workplace absenteeism... - Impact of topiramate migraine prophylaxis on workplace productivity: results from two US randomized, double-blind, placebo-controlled, multicenter trialsJennifer H Lofland
Department of Health Policy Drs Lofland, Gagne, and Pizzi, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA
J Occup Environ Med 49:252-7. 2007..We conducted this study to determine whether topiramate at 100 mg/d for the treatment of migraine headache is associated with improved productivity in the workplace...